EXELON (rivastigmine)
MILD TO MODERATE ALZHEIMER'S TYPE DEMENTIA·+2
Novartis Pharmaceuticals
Indication
Dementia associated with Parkinson's disease
Dementia associated with Parkinson's disease is an acquired, progressive neurocognitive syndrome affecting individuals with established Parkinson's disease, typically developing several years after the onset of motor symptoms. Read more about Dementia associated with Parkinson's disease
25 drugs 24 manufacturers
Drugs that treat it
Common Dementia associated with Parkinson's disease therapies.
RIVASTIGMINE (rivastigmine tartrate)
ALZHEIMER'S DISEASE AGENTS·MILD TO MODERATE ALZHEIMER'S TYPE DEMENTIA·+2
DR.REDDY'S LAB
RIVASTIGMINE (rivastigmine tartrate)
ALZHEIMER'S DISEASE AGENTS·MILD TO MODERATE ALZHEIMER'S TYPE DEMENTIA·+2
SUN PHARMACEUTI
RIVASTIGMINE (rivastigmine tartrate)
ALZHEIMER'S DISEASE AGENTS·MILD TO MODERATE ALZHEIMER'S TYPE DEMENTIA·+2
AHP
RIVASTIGMINE (rivastigmine tartrate)
ALZHEIMER'S DISEASE AGENTS·MILD TO MODERATE ALZHEIMER'S TYPE DEMENTIA·+2
BRECKENRIDGE
RIVASTIGMINE (rivastigmine tartrate)
MILD TO MODERATE ALZHEIMER'S TYPE DEMENTIA·+2
WATSON LABS
RIVASTIGMINE (rivastigmine tartrate)
MILD TO MODERATE ALZHEIMER'S TYPE DEMENTIA·+2
MCKESSON PACKAG
RIVASTIGMINE (rivastigmine tartrate)
MILD TO MODERATE ALZHEIMER'S TYPE DEMENTIA·+2
ACTAVIS PHARMA,
RIVASTIGMINE (rivastigmine tartrate)
ALZHEIMER'S DISEASE AGENTS·MILD TO MODERATE ALZHEIMER'S TYPE DEMENTIA·+2
MACLEODS PHARMA
Filter & compare in the drug finder →Opens the drug finder with Dementia associated with Parkinson's disease preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonDementia associated with Parkinson's disease is an acquired, progressive neurocognitive syndrome affecting individuals with established Parkinson's disease, typically developing several years after the onset of motor symptoms.
It is primarily characterized by subcortical and frontal-executive cognitive deficits—marked by prominent impairments in attention, executive function, processing speed, and visuospatial abilities, frequently accompanied by visual hallucinations and fluctuating alertness.
Pathophysiologically, the central nervous system undergoes widespread neurodegeneration driven by the propagation of cortical and limbic alpha-synuclein aggregates (Lewy bodies and Lewy neurites), compounded by profound cholinergic deficits originating from the basal forebrain.
- nih.gov
Dementia associated with Parkinson's disease is an acquired, progressive neurocognitive syndrome affecting individuals with established Parkinson's disease, typically developing several years after the onset of motor symptoms
- clevelandclinic.org
Dementia associated with Parkinson's disease is an acquired, progressive neurocognitive syndrome affecting individuals with established Parkinson's disease, typically developing several years after the onset of motor symptoms
- nih.gov
It is primarily characterized by subcortical and frontal-executive cognitive deficits—marked by prominent impairments in attention, executive function, processing speed, and visuospatial abilities, frequently accompanied by visual hallucinations and fluctuating alertness Pathophysiologically, the central nervous system undergoes widespread neurodegeneration driven by the propagation of cortical and limbic alpha-synuclein aggregates (Lewy bodies and Lewy neurites), compounded by profound choliner...
- nih.gov
It is primarily characterized by subcortical and frontal-executive cognitive deficits—marked by prominent impairments in attention, executive function, processing speed, and visuospatial abilities, frequently accompanied by visual hallucinations and fluctuating alertness Pathophysiologically, the central nervous system undergoes widespread neurodegeneration driven by the propagation of cortical and limbic alpha-synuclein aggregates (Lewy bodies and Lewy neurites), compounded by profound choliner...
- nih.gov
It is primarily characterized by subcortical and frontal-executive cognitive deficits—marked by prominent impairments in attention, executive function, processing speed, and visuospatial abilities, frequently accompanied by visual hallucinations and fluctuating alertness
- medlink.com
It is primarily characterized by subcortical and frontal-executive cognitive deficits—marked by prominent impairments in attention, executive function, processing speed, and visuospatial abilities, frequently accompanied by visual hallucinations and fluctuating alertness Pathophysiologically, the central nervous system undergoes widespread neurodegeneration driven by the propagation of cortical and limbic alpha-synuclein aggregates (Lewy bodies and Lewy neurites), compounded by profound choliner...
- alzra.org
Pathophysiologically, the central nervous system undergoes widespread neurodegeneration driven by the propagation of cortical and limbic alpha-synuclein aggregates (Lewy bodies and Lewy neurites), compounded by profound cholinergic deficits originating from the basal forebrain
Personalize your experience
Follow Dementia associated with Parkinson's disease and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.